1. Home
  2. ARMP vs ANIK Comparison

ARMP vs ANIK Comparison

Compare ARMP & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.35

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$9.86

Market Cap

133.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
ANIK
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.7M
133.1M
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
ARMP
ANIK
Price
$7.35
$9.86
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$9.00
$16.00
AVG Volume (30 Days)
99.2K
162.7K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,054,000.00
$112,806,000.00
Revenue This Year
$8.43
N/A
Revenue Next Year
N/A
$4.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.55
52 Week Low
$0.90
$7.87
52 Week High
$16.34
$18.37

Technical Indicators

Market Signals
Indicator
ARMP
ANIK
Relative Strength Index (RSI) 65.33 53.34
Support Level $6.81 $9.76
Resistance Level $7.40 $10.17
Average True Range (ATR) 0.67 0.37
MACD -0.03 -0.02
Stochastic Oscillator 89.99 60.93

Price Performance

Historical Comparison
ARMP
ANIK

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Share on Social Networks: